However, there is a lack of data to suggest whether HIF-1α is important for the development of NAFLD in humans and for any impact of TCA cycle dysfunction on PHD catalytic activity. The gene discussed is HIF1A; the disease is metabolic dysfunction-associated steatotic liver disease.